MeadowBrook Investment Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200
Closed -$2.77K 301
2024
Q4
$2.77K Hold
200
﹤0.01% 299
2024
Q3
$3.35K Hold
200
﹤0.01% 290
2024
Q2
$4.13K Hold
200
﹤0.01% 273
2024
Q1
$4.95K Hold
200
﹤0.01% 274
2023
Q4
$7.27K Buy
+200
New +$7.7K 0.01% 261

Other funds holding PRTA

MeadowBrook Investment Advisors's PRTA Position: Q1 2025 in Review

MeadowBrook Investment Advisors sold out of Prothena Corp (PRTA) in Q1 2025, closing a stake of 200 shares — an estimated $2.77K sold.

MeadowBrook Investment Advisors first reported a position in PRTA in Q4 2023 and held it in 5 quarters. The position peaked at $7.27K in Q4 2023. 161 funds tracked by Wall St. Rank hold PRTA as of Q1 2025.

  • MeadowBrook Investment Advisors reported no remaining Prothena Corp position as of Q1 2025 after selling out during the quarter.
  • MeadowBrook Investment Advisors sold 200 Prothena Corp shares in Q1 2025, an estimated $2.77K.
  • MeadowBrook Investment Advisors first reported a position in Prothena Corp in Q4 2023 and held it in 5 quarters.
  • MeadowBrook Investment Advisors's Prothena Corp position peaked at $7.27K in Q4 2023.
  • 161 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2025.

Based on MeadowBrook Investment Advisors's 13F filing for Q1 2025, filed 30 Apr 2025.